|

Paclitaxcel Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Medical University of South Carolina1

Indications

  • Elevated Tumor-Infiltrating Lymphocytes1
  • Triple Negative Breast Cancer (TNBC)1
  • Breast Cancer1
  • Cancer1

Syracuse, New York1 trial

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

SUNY Upstate Medical University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.